Home
On-Demand
Industrie
FAQ
Login MyUpdate
Home
On-Demand
Industrie
FAQ
Login MyUpdate
Schlagwort
TNBC
Mammakarzinom – triple negativ
Mammakarzinom – triple negativ
A-BRAVE
/
ASCENT
/
BEGONIA
/
BRCA1
/
Carboplatin
/
gBRCA1/2 Mutation
/
GEPAR-Nuevo
/
IMPASSION-130
/
IMPASSION-131
/
KEYNOTE-119
/
KEYNOTE-355
/
KEYNOTE-522
/
metaplastisches Mammakarzinom
/
non-pCR
/
PARP-Inhibitoren
/
Taxan/Platin-haltig
/
TNBC
/
Triple-negatives Mammakarzinom
/
TROPION
/
tumor-infiltrierende Lymphozyten
Mammakarzinom non-luminal
Mammakarzinom non-luminal
APT-StudieB
/
Biomarker-Programm
/
Capecitabine
/
Cochrane Analyse
/
Darm-Mikrobiom
/
ExteNET
/
HER2-positives eBC
/
NACT
/
Neratinib
/
Non-Luminal
/
Olaparib
/
Pertuzumab
/
PHERGain
/
pT1b/pT1c pN0
/
Resttumor
/
sTILs
/
Therapiealgorithmus
/
TNBC
/
Tripelnegativ
/
Tumorinfiltrierende Lymphozyten
